Description

Nivamo Injection (Nivolumab) 40mg/4ml – Uses, Side Effects, Dosage & Price in Pakistan

Nivamo Injection (Nivolumab) 40mg/4ml is an anticancer medicine used as part of immunotherapy for several types of cancer. It contains nivolumab, a programmed death receptor-1 (PD-1) blocking monoclonal antibody. By blocking the PD-1 pathway, nivolumab helps the immune system recognize and attack cancer cells more effectively. The 40mg/4ml strength contains 10mg of nivolumab per mL and is supplied as a single-dose vial for intravenous infusion.

Nivamo is a prescription medicine and should only be administered by a qualified healthcare professional under the supervision of an oncologist. The exact treatment plan depends on the type and stage of cancer, previous treatments, the patient’s overall condition, and whether nivolumab is being used alone or with other medicines.

Nivamo Injection (Nivolumab) Used For

Nivolumab is used in the treatment of several cancers. Depending on the specific indication, it may be used alone or together with other cancer medicines. Approved uses of nivolumab include certain forms of melanoma, non-small cell lung cancer, renal cell carcinoma, urothelial carcinoma, head and neck cancer, colorectal cancer, esophageal cancer, gastric or gastroesophageal junction cancer, hepatocellular carcinoma, and other specific cancers. The exact approved indication can depend on tumor type, disease stage, biomarker status, previous treatment, and combination therapy.

Because cancer treatment is highly individualized, Nivamo should not be started simply based on the diagnosis. An oncologist determines whether nivolumab is appropriate for a particular patient.

How Nivamo Injection (Nivolumab) Works

Nivolumab works by blocking the PD-1 receptor on immune cells. Cancer cells can use the PD-1/PD-L1 pathway to reduce the immune system’s ability to attack them. By blocking this pathway, nivolumab removes an important immune checkpoint and can help T cells respond against cancer cells.

This is different from traditional chemotherapy because nivolumab works by modifying the body’s immune response rather than directly killing rapidly dividing cells.

Nivamo Injection Dosage

The dose of nivolumab is determined by the oncologist according to the cancer being treated and whether it is given alone or with other medicines. Nivolumab regimens can use weight-based or fixed dosing and may be administered at different intervals depending on the approved indication and treatment combination.

The 40mg/4ml vial is a strength of the medicine, not necessarily the complete dose for an individual patient. More than one vial may be required to prepare the prescribed dose.

Nivamo must not be self-administered or dosed without medical supervision. The healthcare team may delay or discontinue treatment if significant immune-mediated adverse reactions occur.

How to Take Nivamo Injection

Nivamo Injection is administered through an intravenous infusion by trained medical staff. It is not intended for self-injection.

Before administration, the solution is inspected for discoloration or particles and prepared according to the approved infusion instructions. Nivolumab can be diluted with 0.9% sodium chloride or 5% dextrose to prepare the intravenous infusion. The medicine should not be shaken.

Patients are monitored during and after infusion for possible infusion-related reactions. The infusion may be interrupted, slowed, or discontinued if a significant reaction develops.

Nivamo Injection Side Effects

Like other immunotherapy medicines, Nivamo can cause side effects. Common or clinically important adverse effects may include:

• Tiredness or weakness
• Nausea
• Diarrhea
• Constipation
• Reduced appetite
• Skin rash or itching
• Cough or shortness of breath
• Fever
• Headache
• Muscle or joint pain
• Abdominal discomfort
• Changes in thyroid function
• Abnormal liver function tests

Not every patient experiences these effects. Patients should tell their healthcare team about new or worsening symptoms rather than stopping treatment themselves.

Serious Side Effects and Warnings

Nivolumab can cause immune-mediated side effects because it activates the immune system. These reactions can affect almost any organ and may sometimes become severe or life-threatening. Important reactions include pneumonitis, colitis, hepatitis, endocrinopathies, skin reactions, nephritis, and other immune-mediated problems.

Contact the treating doctor promptly if symptoms such as the following occur:

• New or worsening cough or breathing difficulty
• Severe or persistent diarrhea
• Severe abdominal pain
• Yellowing of the skin or eyes
• Dark urine
• Significant skin rash or blistering
• Severe weakness or unusual tiredness
• Changes in vision
• Reduced urination
• Severe headache or confusion
• Persistent fever

Nivolumab can also cause infusion-related reactions. Medical staff should monitor the patient and manage reactions according to their severity.

Precautions Before Using Nivamo

Before treatment, tell the oncologist about any previous immune-related problems, autoimmune disease, organ transplant, liver disease, kidney problems, lung disease, thyroid disorders, or previous serious reactions to immunotherapy.

Patients should also inform their doctor about all prescription medicines, over-the-counter medicines, vitamins, and supplements they are taking.

Nivolumab may affect different organs through immune activation, so regular medical monitoring is an important part of treatment.

Nivamo Injection Drug Interactions

Nivolumab does not have the same type of drug-metabolism interactions as many conventional medicines. However, medicines that affect the immune system can be clinically important.

Tell the healthcare provider if you are receiving corticosteroids, immunosuppressive medicines, other immunotherapy drugs, or cancer treatments. Nivolumab is also frequently used in combination with medicines such as ipilimumab or chemotherapy in specific treatment regimens, but these combinations must follow an oncologist’s prescribed protocol.

Nivamo During Pregnancy

Nivolumab may cause fetal harm because it affects immune-system activity. Women who are pregnant, planning pregnancy, or who could become pregnant should discuss the risks with their healthcare provider before treatment.

The oncologist may recommend appropriate contraception during treatment and for a specified period afterward according to the current prescribing information. Patients should not stop cancer treatment or contraception without discussing it with their healthcare provider.

Nivamo Monitoring

Patients receiving Nivamo require regular monitoring throughout treatment. Doctors may check:

• Liver enzymes and bilirubin
• Kidney function and creatinine
• Thyroid function
• Blood counts when clinically appropriate
• Symptoms of lung inflammation
• Bowel symptoms
• Skin changes
• Hormonal or endocrine symptoms
• Infusion reactions
• Signs of infection or other complications

The current prescribing information specifically recommends baseline and periodic evaluation of liver enzymes, creatinine, and thyroid function because immune-mediated reactions can affect these organs.

Nivamo Injection Storage

Nivamo/Nivolumab injection should be handled and stored according to the product’s approved storage requirements. For the reference nivolumab product, unopened vials are stored refrigerated at 2°C to 8°C (36°F to 46°F) and protected from light in the original package. The vial should not be frozen or shaken.

Preparation and administration should be performed by qualified healthcare professionals.

Nivamo Injection 40mg/4ml Price in Pakistan

The price of Nivamo Injection 40mg/4ml in Pakistan can vary depending on the manufacturer, supplier, availability, import status, and pharmacy or hospital. Cancer medicines may also have changing prices because of import and supply conditions.

For the latest availability and Nivamo Injection 40mg/4ml price in Pakistan, patients or caregivers can contact Impo Medic and confirm the current product details before ordering.

How to Buy Nivamo Injection in Pakistan

Nivamo Injection is a prescription oncology medicine and should be purchased from a reliable medicine supplier. Before buying, verify the strength, packaging, manufacturer, batch information, and expiry date.

Impo Medic can help patients in Pakistan check the availability of oncology medicines such as Nivamo Injection. Because nivolumab is administered by intravenous infusion, patients should arrange administration through an appropriate hospital, clinic, or qualified healthcare professional.

Frequently Asked Questions About Nivamo Injection (Nivolumab)

What is Nivamo Injection 40mg/4ml used for?

Nivamo contains nivolumab and is used for specific types of cancer as an immunotherapy medicine. The exact indication depends on the cancer type, stage, previous treatment, and prescribed treatment combination.

Is Nivamo Injection chemotherapy?

Nivamo is an immunotherapy medicine rather than a conventional chemotherapy drug. It is a PD-1 blocking antibody that helps activate the immune response against cancer cells.

How is Nivamo 40mg/4ml given?

Nivamo is given as an intravenous infusion by trained healthcare professionals. It is not intended for self-injection.

Can Nivamo cause serious side effects?

Yes. Nivolumab can cause serious immune-mediated reactions involving organs such as the lungs, liver, intestines, kidneys, skin, and endocrine glands. Early reporting of new symptoms is important.

How should Nivamo be stored?

The reference nivolumab injection should be refrigerated at 2°C to 8°C, protected from light, and should not be frozen or shaken.

Where can I check Nivamo Injection price in Pakistan?

For current availability and pricing, patients can contact Impo Medic and confirm the latest product information before purchase.